cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

McLean, John W., Tomlinson, James E., Kuang, Wun-Jing, Eaton, Dan L., Chen, Ellson Y., Fless, Gunther M., Scanu, Angelo M., Lawn, Richard M.·1987·Nature

Cited by (1,002)

Items 201–300 of 1,002

  1. Lipoprotein(a) catabolism: a case of multiple receptors
    McCormick, Sally P.A., Schneider, Wolfgang J. · 2019 · Pathology
  2. Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux
    Lars B. Nielsen · 1999 · Atherosclerosis
  3. Cellular Receptors in the Regulation of Plasmin Generation
    Katherine A. Hajjar · 1995 · Thrombosis and Haemostasis
  4. High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction.
    Shuzo Shintani, S. Kikuchi, Hideo Hamaguchi · 1993 · Stroke
  5. Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
    Hubert Scharnagl, Tatjana Stojaković, Benjamin Dieplinger, Hans Dieplinger, Gertraud Erhart, Gerhard Max Kostner, Markus Herrmann, Winfried März, Tanja B. Grammer · 2019 · Atherosclerosis
  6. Molecular basis for “null” lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon.
    Ann L. White, James E. Hixson, David L. Rainwater, Robert E. Lanford · 1994 · Journal of Biological Chemistry
  7. The Number of Identical Kringle IV Repeats in Apolipoprotein(a) Affects Its Processing and Secretion by HepG2 Cells
    Christoph Brunner, Eva‐Maria Lobentanz, Attila Pethö‐Schramm, Angelika Ernst, Chantal Kang, Hans Dieplinger, Hans‐Joachim Müller, Gerd Utermann · 1996 · Journal of Biological Chemistry
  8. Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it.
    Eija Salonen, Matti Jauhiainen, Luciano Zardi, Antti I. Vaheri, Christian Ehnholm · 1989 · The EMBO Journal
  9. Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related macular degeneration.
    Handa, James T., Cano, Marisol, Wang, Lei, Datta, Sayantan, Liu, Tongyun · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  10. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside
    Marcovina, Santica M., Koschinsky, Marlys L. · 2003 · Current Opinion in Lipidology
  11. Lipoprotein a inhibits streptokinase-mediated activation of human plasminogen
    Jay M. Edelberg, Mario Gonzalez–Gronow, Salvatore Vincent Pizzo · 1989 · Biochemistry
  12. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation
    Ari M. Ezratty, Daniel I. Simon, Joseph Loscalzo · 1993 · Biochemistry
  13. ‘Silent’ Cerebral Infarction Is Associated With Hypercoagulability, Endothelial Cell Damage, and High Lp(a) Levels in Elderly Japanese
    Kazuomi Kario, Takefumi Matsuo, Hiroko Kobayashi, Reiko Asada, Miyako Matsuo · 1996 · Arteriosclerosis Thrombosis and Vascular Biology
  14. Tissue-Specific Expression, Developmental Regulation, and Chromosomal Mapping of the Lecithin: Cholesterol Acyltransferase Gene
    Craig H. Warden, Cord Langner, Jeffrey I. Gordon, Benjamin Aaron Taylor, J W McLean, Aldons Jake Lusis · 1989 · Journal of Biological Chemistry
  15. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator
    Jay M. Edelberg, Mario Gonzalez–Gronow, Salvatore Vincent Pizzo · 1990 · Thrombosis Research
  16. Lipoprotein(a) and ischemic cerebrovascular disease in young adults.
    Masao Nagayama, Y Shinohara, Tomiko Nagayama · 1994 · Stroke
  17. Lipoprotein(a) and ischemic heart disease—A causal association? A review
    Pia R. Kamstrup · 2010 · Atherosclerosis
  18. Urinary Excretion of Apo(a) Fragments
    Karam Kostner, Gerald Maurer, Kurt Huber, Thomas Stefenelli, Hans Dieplinger, Ernst Steyrer, Gert M. Kostner · 1996 · Arteriosclerosis Thrombosis and Vascular Biology
  19. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects
    Tjerk W.A. de Bruin, Harrold H.J.J. van Barlingen, Mieke D. Trip, A-R. van der Vuurst de Vries, M J Akveld, D.W. Erkelens · 1993 · The Journal of Clinical Endocrinology & Metabolism
  20. Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid
    David Crook, Mandeep S. Sidhu, Mary Seed · 1992 · Atherosclerosis
  21. Variants of human tissue‐type plasminogen activator that lack specific structural domains of the heavy chain.
    M J Gething, Beverly S. Adler, Jeri Ann Boose · 1988 · The EMBO Journal
  22. Lipoprotein (a) and plasminogen are immunochemically related
    István Karádi, Gerhard Max Kostner, Anni Gries · 1988 · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
  23. Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular Events
    Jacqueline Suk Danik, Nader Rifai, Julie E. Buring, Paul M. Ridker · 2008 · Journal of the American College of Cardiology
  24. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles.
    Y.F.Nicholas Perombelon, Anne K. Soutar, Brian L. Knight · 1994 · Journal of Clinical Investigation
  25. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.
    Alexander C. Liu, Richard M. Lawn, Judy G. Verstuyft, E M Rubin · 1994 · Journal of Lipid Research
  26. Dietary regulation of fibrinolytic factors
    Margarete Mehrabian, J PETER, R BARNARD, Aldons Jake Lusis · 1990 · Atherosclerosis
  27. An alternatively processed mRNA generated from human hepatocyte growth factor gene
    Keiji Miyazawa, Akiko Kitamura, Daiji Naka, Naomi Kitamura · 1991 · European Journal of Biochemistry
  28. Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis
    Michael B. Boffa · 2022 · Atherosclerosis
  29. Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives
    Pierandrea Vinci, Filippo Giorgio Di Girolamo, Emiliano Panizon, Letizia Maria Tosoni, Carla Cerrato, Federica Pellicori, Nicola Altamura, Alessia Pirulli, Michele Zaccari, Chiara Biasinutto et al. · 2023 · International Journal of Environmental Research and Public Health
  30. Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients
    AKINLOLU O. OJO, Julie A. Hanson, Robert A. Wolfe · 1999 · Kidney International
  31. Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor
    Joachim Thiery, Victor W. Armstrong, Jürgen Schleef · 1988 · Journal of Molecular Medicine
  32. Lipoprotein(a): more interesting than ever after 50 years
    Dubé, Joseph B., Boffa, Michael B., Hegele, Robert A., Koschinsky, Marlys L. · 2012 · Current Opinion in Lipidology
  33. Lipoprotein(a): A Unique Risk Factor for Cardiovascular Disease
    Erdembileg Anuurad, Michael B. Boffa, Marlys L. Koschinsky, Lars Berglund · 2006 · Clinics in Laboratory Medicine
  34. Expression and Function of the Ror‐Family Receptor Tyrosine Kinases During Development: Lessons from Genetic Analyses of Nematodes, Mice, and Humans
    Akinori Yoda, Isao Oishi, Yasuhiro Minami · 2003 · Journal of Receptors and Signal Transduction
  35. Effect of HELP‐LDL‐apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post‐treatment return to baseline levels
    Victor W. Armstrong, Jürgen Schleef, Joachim Thiery, Rainer Muche, Peter Schuff‐Werner, Thomas Eisenhauer, Dietrich Seidel · 1989 · European Journal of Clinical Investigation
  36. The hemostatic system and coronary heart disease
    Anders Hamsten · 1993 · Thrombosis Research
  37. Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor.
    VW Armstrong, Bärbel Harrach, Horst Robenek · 1990 · Journal of Lipid Research
  38. C/T Polymorphism in the 5′ Untranslated Region of the Apolipoprotein(a) Gene Introduces an Upstream ATG and Reduces In Vitro Translation
    Bernice R. Zysow, Gisela E. Lindahl, David P. Wade, Brian L. Knight, Richard M. Lawn · 1995 · Arteriosclerosis Thrombosis and Vascular Biology
  39. Dominant Negative Effect of TGF-β1 and TNF-α on Basal and IL-6–Induced Lipoprotein(a) and Apolipoprotein(a) mRNA Expression in Primary Monkey Hepatocyte Cultures
    Randy Ramharack, Derek Barkalow, Mark A. Spahr · 1998 · Arteriosclerosis Thrombosis and Vascular Biology
  40. Enhanced Association of Platelet-activating Factor Acetylhydrolase with Lipoprotein (a) in Comparison with Low Density Lipoprotein
    Christopher Blencowe, Albin Hermetter, Gert M. Kostner, Hans Peter Deigner · 1995 · Journal of Biological Chemistry
  41. Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-.ANG. resolution
    Anne M. Mulichak, Alexander Tulinsky, K. G. Ravichandran · 1991 · Biochemistry
  42. Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects
    Knight, Brian L., Perombelon, Y.F.Nicholas, Soutar, Anne K., Wade, David P., Seed, Mary · 1991 · Atherosclerosis
  43. Lp(a) lipoprotein: Relationship to cardiovascular disease risk factors, exercise, and estrogen
    Rogerio A. Løbo, Morris Notelovitz, Leslie Bernstein, Farouk Y. Khan, Ronald K. Ross, Wellington L. Paul · 1992 · American Journal of Obstetrics and Gynecology
  44. Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism
    Rossella Marcucci, Agatina Alessandrello Liotta, Anna Paola Cellai · 2003 · The American Journal of Medicine
  45. Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.
    Anthony David Mbewu, Deepak Bhatnagar, Paul N. Durrington, Linda P. Hunt, M. Ishola, Sharon Arrol, Mike Mackness, Paul Lockley, J Paul Miller · 1991 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
  46. Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 32−36 of Human Apolipoprotein(a)
    Angelika Ernst, Marion Helmhold, Christoph Brunner, Attila Pethö‐Schramm, Victor W. Armstrong, Hans‐Joachim Müller · 1995 · Journal of Biological Chemistry
  47. Structure and functional expression of the acid-labile subunit of the insulin-like growth factor-binding protein complex.
    Steven R. Leong, Robert C. Baxter, T R Camerato · 1992 · Molecular Endocrinology
  48. In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients
    Michael E. Frischmann, Florian Kronenberg, Evi Trenkwalder, Juergen Rolf Schaefer, Horst Schweer, Benjamin Dieplinger, P. Koenig, Katsunori Ikewaki, Hans Dieplinger · 2007 · Kidney International
  49. Heritable Thrombophilia and Hypofibrinolysis
    Charles J. Glueck · 1999 · Archives of Ophthalmology
  50. Lipoprotein(a): New insights into mechanisms of atherogenesis and thrombosis
    Arjun Deb, Noel M. Caplice · 2004 · Clinical Cardiology
  51. THE ROLE OF LIPOPROTEIN(a) IN ATHEROGENESIS AND THROMBOSIS
    Katherine A. Hajjar, Ralph L. Nachman · 1996 · Annual Review of Medicine
  52. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
    Markku S. Nieminen, Kari J. Mattila, Katriina Aalto‐Setälä, T Kuusi, Kimmo Kontula, R Kauppinen-Mäkelin, Christian Ehnholm, Matti Jauhiainen, M. Valle, Marja‐Riitta Taskinen · 1992 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
  53. Lipoproteins, nutrition, aging, and atherosclerosis
    Ernst J. Schaefer, Alice Hinda Lichtenstein, Stefania Lamon‐Fava, JR McNamara, José María Ordovás · 1995 · American Journal of Clinical Nutrition
  54. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
    Laurence Hervio, M. John Chapman, Joëlle Thillet · 1993 · Blood
  55. Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect.
    Hans-J�rgen Menzel, Hans Dieplinger, Carolin Lackner, Fritz Hoppichler, June K. Lloyd, David P. R. Muller, Christine Labeur, Philippa J. Talmud, Gerd Utermann · 1990 · Journal of Biological Chemistry
  56. Fibrin as a factor in atherogenesis
    Elspeth B. Smith, W. Douglas Thompson · 1994 · Thrombosis Research
  57. Convergent evolution of apolipoprotein(a) in primates and hedgehog
    Richard M. Lawn, Karen Schwartz, László Patthy · 1997 · Proceedings of the National Academy of Sciences
  58. Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine.
    Vincent Mooser, Santica M. Marcovina, Ann L. White, Helen H. Hobbs · 1996 · Journal of Clinical Investigation
  59. Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variation.
    Marion Helmhold, J Bigge, Rainer Muche · 1991 · Journal of Lipid Research
  60. N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels
    Olov Wiklund, Gunnar Fager, Anders David Ragnar Andersson, Ulf Lundstam, Parvesh Masson, Björn L. Hultberg · 1996 · Atherosclerosis
  61. Prothrombin Kringle-2 Domain Has a Growth Inhibitory Activity against Basic Fibroblast Growth Factor-stimulated Capillary Endothelial Cells
    Tae-Hee Lee, Taiyoun Rhim, Soung Soo Kim · 1998 · Journal of Biological Chemistry
  62. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
    Matthew J. Callow, Judy G. Verstuyft, Ravi Tangirala, Wulf Palinski, Edward M. Rubin · 1995 · Journal of Clinical Investigation
  63. Overview on fibrinolysis: Plasminogen activation pathways on fibrin and cell surfaces
    Eduardo Anglés‐Cano · 1994 · Chemistry and Physics of Lipids
  64. A Novel Drosophila Receptor Tyrosine Kinase Expressed Specifically in the Nervous System
    Isao Oishi, Shin Sugiyama, Zhaojun Liu, Hirohei Yamamura, Yasuyoshi Nishida, Yasuhiro Minami · 1997 · Journal of Biological Chemistry
  65. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein
    Daniel I. Simon, Gunther M. Fless, Angelo M. Scanu, Joseph Loscalzo · 1991 · Biochemistry
  66. Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue.
    Carmen Hagios, Manuel Koch, J. Spring, Matthias Chiquet, Ruth Chiquet‐Ehrismann · 1996 · The Journal of Cell Biology
  67. Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
    Byambaa Enkhmaa, Kristina H. Petersen, Penny M. Kris‐Etherton, Lars Berglund · 2020 · Nutrients
  68. One-step competitive immunochromatographic assay for semiquantitative determination of lipoprotein(a) in plasma
    Sheng Chang Lou, C Patel, S Ching · 1993 · Clinical Chemistry
  69. Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q
    Carole Ober, Alex S. Nord, Emma E. Thompson, Lin Pan, Zheng Tan, Darren A. Cusanovich, Ying Sun, Raluca I. Nicolae, Celina Edelstein, Daniel Schneider et al. · 2009 · Journal of Lipid Research
  70. CC Chemokine I-309 Is the Principal Monocyte Chemoattractant Induced by Apolipoprotein(a) in Human Vascular Endothelial Cells
    Nasreen S. Haque, Xiaoxia Zhang, Deborah L. French · 2000 · Circulation
  71. Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries
    Axel Niendorf, Matthias Rath, Katrin Wolf · 1990 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  72. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments
    Didier Rouy, Marlys L. Koschinsky, Valerie Fleury, John Chapman, Eduardo Anglés‐Cano · 1992 · Biochemistry
  73. Apolipoprotein(a) (Apo(a)) Glycoprotein Isoforms Result from Size Differences in Apo(a) mRNA in Baboons
    James E. Hixson, Marjorie L. Britten, G S Manis · 1989 · Journal of Biological Chemistry
  74. Genetic architecture and evolution of the lipoprotein(a) trait
    Utermann, Gerd · 1999 · Current Opinion in Lipidology
  75. Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a)
    Sharma, Monika, Redpath, Gregory M., Williams, Michael J.A., McCormick, Sally P.A. · 2017 · Circulation Research
  76. LIPOPROTEIN(α) IN HEALTH AND DISEASE
    Christopher D. Byrne, SH Wild · 1994 · International Journal of Clinical Practice
  77. Atherosclerosis and the coagulation system
    W. Douglas Thompson, E. B. Smith · 1989 · The Journal of Pathology
  78. Incidence of Lp(a) Lipoprotein among Populations
    Gösta H. Dahlén · 1990 · Elsevier eBooks
  79. Inhibition of Angiogenesis and Angiogenesis-dependent Tumor Growth by the Cryptic Kringle Fragments of Human Apolipoprotein(a)
    Jang‐Seong Kim, Jihoon Chang, Hyun-Kyung Yu, Jin‐Hyung Ahn, Jung Sun Yum, Suk‐Keun Lee, Kyung‐Hwan Jung, Doo-Hong Park, Yeup Yoon, Si-Myung Byun et al. · 2003 · Journal of Biological Chemistry
  80. Lipoprotein(a) and acute-phase proteins in acute myocardial infarction
    Lisbeth Slunga Birgander, O. Johnson, G. Dahlén, Sture Eriksson, Lisbeth Slunga Birgander · 1992 · Scandinavian Journal of Clinical and Laboratory Investigation
  81. Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
    Stefania Lamon‐Fava, Santica M. Marcovina, John J. Albers, Hal Kennedy, Carl DeLuca, Charles C. White, L. Adrienne Cupples, Judith R McNamara, LEO J. SEMAN, Vanina Bongard et al. · 2011 · Journal of Lipid Research
  82. Lipoprotein(a) Levels in Black and White Children and Adolescents With IDDM
    Lynne L. Levitsky, Angelo M. Scanu, Samuel H. Gould · 1991 · Diabetes Care
  83. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.
    Nataya W. Boonmark, Xing Jian Lou, Z J Yang, Karen Schwartz, Jie Lin Zhang, E M Rubin, Richard M. Lawn · 1997 · Journal of Clinical Investigation
  84. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
    Vuong N. Trieu, Thomas F. Zioncheck, Richard M. Lawn · 1991 · Journal of Biological Chemistry
  85. Update on the NCEP ATP-III emerging cardiometabolic risk factors
    Robert H. Eckel, Marc‐André Cornier · 2014 · BMC Medicine
  86. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium
    Nasreen S. Haque, John T. Fallon, Mark B. Taubman · 2001 · Blood
  87. Structural Elucidation of the N- andO-Glycans of Human Apolipoprotein(a)
    Brett Garner, Anthony H. Merry, Louise Royle, David John Harvey, Pauline Mary Rudd, Joëlle Thillet · 2001 · Journal of Biological Chemistry
  88. Molecular cloning of a histidine-rich Ca2+-binding protein of sarcoplasmic reticulum that contains highly conserved repeated elements
    Sandra L. Hofmann, Joseph L. Goldstein, Kim Orth · 1989 · Journal of Biological Chemistry
  89. Genetic basis of lipoprotein disorders.
    Jan L. Breslow · 1989 · Journal of Clinical Investigation
  90. Inflammation and Cardiovascular Disease: The Future
    Natalie Arnold, Katharina Lechner, Christoph Waldeyer, Michael David Shapiro, Wolfgang Köenig · 2021 · European Cardiology Review
  91. Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology
    Marlys L. Koschinsky, Michael B. Boffa · 2022 · Atherosclerosis
  92. The metabolism of lipoprotein (a): an ever-evolving story
    Gissette Reyes-Soffer, Henry N. Ginsberg, Rajasekhar Ramakrishnan · 2017 · Journal of Lipid Research
  93. Selective Inhibition by Kringle 5 of Human Plasminogen on Endothelial Cell Migration, an Important Process in Angiogenesis
    Weidong-Richard Ji, Laura G. Barrientos, Miguel Llinás, Hilary Gray, Xavier C. Villarreal, Melanie E. DeFord, Francis Castellino, Robert A. Kramer, Pamela A. Trail · 1998 · Biochemical and Biophysical Research Communications
  94. Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-.ANG. resolution
    Abraham M. de Vos, Mark H. Ultsch, Robert F. Kelley, Kaillathe Padmanabhan, Alexander Tulinsky, Mary L. Westbrook, Anthony A. Kossiakoff · 1992 · Biochemistry
  95. Long term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study
    W. Hänggi, Kurt Lippuner, Walter Riesen, Phillippe Jaeger, Martin Birkhäuser · 1997 · BJOG An International Journal of Obstetrics & Gynaecology
  96. Apolipoprotein B-containing lipoproteins in atherogenesis
    Jan Borén, Chris J. Packard, Christoph J. Binder · 2025 · Nature Reviews Cardiology
  97. Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).
    Vincent Mooser, Miguel C. Seabra, Mehnur Abedin, Katherine T. Landschulz, Santica M. Marcovina, Helen H. Hobbs · 1996 · Journal of Clinical Investigation
  98. The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma.
    Ernst Steyrer, Srdan Durovic, Saša Frank · 1994 · Journal of Clinical Investigation
  99. Defensin Stimulates the Binding of Lipoprotein (a) to Human Vascular Endothelial and Smooth Muscle Cells
    Abd Al‐Roof Higazi, Ehud Lavi, Khalil Bdeir · 1997 · Blood
  100. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin
    Raghuvir Krishnaswamy Arni, Kaillathe Padmanabhan, Kaillathe Padmanabhan · 1993 · Biochemistry